gen2
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 13, 2014 (NCT04313868)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06391918 | Phase 1 | Mar 4, 2024 | GenVivo, Inc. |
| NCT04313868 | Phase 1 | Jun 13, 2014 | GenVivo, Inc., Makati Medical Center, Manila Doctors Hospital, National Kidney and Transplant Institute, Philippines, St. Luke's Medical Center, Philippines |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GenVivo, Inc. | For profit | 2 | 2 | 1 | 2014 |
| Makati Medical Center | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Manila Doctors Hospital | Academic/Hospital | 1 | 0 | 1 | 2014 |
| National Kidney and Transplant Institute, Philippines | Academic/Hospital | 1 | 0 | 1 | 2014 |
| St. Luke's Medical Center, Philippines | Academic/Hospital | 1 | 0 | 1 | 2014 |
5 organizations
Page 1 / 1